Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2503 (LINC02503)

Target
LINC02503
Molecular classification
Long intergenic non-coding RNA, Long non-coding RNA (lncRNA)
01

Overview

Long intergenic non-protein coding RNA 2503 (LINC02503) is a member of the lincRNA family, comprising RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes. LincRNAs, including LINC02503, are generally believed to function in the nucleus where they can remodel chromatin, regulate transcription, stabilize RNAs, and potentially act as enhancers. They are characterized by tissue specificity and may fine-tune the expression of neighboring genes by both sequence-dependent and sequence-independent mechanisms. While lincRNAs are broadly implicated in critical regulatory cellular processes and are increasingly associated with disease states such as cancer, specific functional and clinical evidence relating to LINC02503 itself is currently lacking. No interacting drugs, approved therapeutic targeting, biomarker utility, or safety concerns are documented for this molecule.

Other names
LINC02503
02

Biological functions

Chromatin remodelingTranscription regulationRNA stabilizationPossible enhancer-associated activityFine-tuning expression of neighboring genes
03

Disease associations

Potential involvement in cancer and other diseases (role generic to lincRNAs, not specific for LINC02503 due to lack of direct annotation)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2503 (LINC02503).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2503 (LINC02503).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call